Truist Financial taps debt markets with a multi-billion dollar issuance, aiming to strengthen its funding base while sustaining shareholder returns amidst a shifting interest rate landscape.
Boeing reports a surge in orders and finalizes its Spirit AeroSystems buyout, aiming to solidify its supply chain. However, ongoing production challenges and regulatory scrutiny cast a shadow over its ambitious ramp-up plans.
As Americans begin filing their 2025 returns, a landmark tax overhaul passed by Congress is set to deliver significant savings for families, hourly workers, and homeowners through expanded deductions and new credits.
Standex International's fiscal Q2 results showcase robust organic growth and record order intake, driven by a multi-year strategic pivot towards new product innovation and high-growth markets like grid infrastructure and defense.
Orchid Island Capital (ORC) reported robust fourth-quarter earnings, driven by a stable interest rate environment, tightening mortgage spreads, and lower funding costs. The REIT continued its strategic pivot into higher-coupon mortgage pools with built-in prepayment protection.
Chemical and ammunition manufacturer Olin Corporation reported fourth-quarter results that missed internal forecasts, pressured by plant disruptions, supply issues, and a sharp year-end drop in chlorine demand. Executives emphasized cash preservation and cost control while navigating what they term an extended market downturn.
Invesco Mortgage Capital (IVR) posted robust fourth-quarter results, buoyed by a calmer interest rate environment and outperformance in agency mortgage-backed securities. Executives detailed strategic portfolio positioning amid spread tightening and signaled cautious optimism for the year ahead.
As FactSet's stock price fell 45% over the past year, investment firm McDonald Capital Investors made a significant $24 million purchase, underscoring a long-term conviction in the financial data provider's resilient, high-margin subscription business.
Novo Nordisk's newly launched oral GLP-1 drug, amycretin, has seen explosive initial demand in the U.S., potentially setting the stage for a significant financial turnaround and stock rally after a challenging previous year.
Drivers across the Midwest are feeling the pinch as regional gasoline prices rose for a second consecutive week, with the current average now sitting 9 cents higher than last month. While still below the national average, the steady increase signals potential pressure on household budgets.
As SpaceX nears a deal to acquire xAI, analysts see a straightforward step in Elon Musk's grand vision. However, integrating the publicly traded Tesla into a sprawling 'Musk Inc.' conglomerate presents a far more complex financial and regulatory challenge for investors.
Verizon shares surged nearly 12% after quarterly results and guidance exceeded expectations, highlighting robust subscriber gains and a massive new share repurchase program aimed at rewarding investors.
Ontario's regulated online gambling sector capped a record-breaking year with a strong December performance, generating over $425 million in monthly revenue and pushing the annual total past the $4 billion mark, as the province's market continues to outpace growth seen in many U.S. states.
Despite a new U.S. framework for involvement, extracting Greenland's rare earth metals is hampered by Arctic extremes, local political opposition, and strained transatlantic ties.
Despite political pressure and vast reserves, U.S. oil majors ExxonMobil and Chevron are taking a cautious stance on new spending in Venezuela, demanding legal stability and fiscal reforms before committing fresh capital, even as they signal long-term interest.
Amidst a challenging macro landscape, telecom operator VEON Ltd. is posting robust growth in its core frontier markets while aggressively expanding its digital ecosystem. With a valuation significantly below peers, analysts are debating whether the market is overlooking a hidden gem or rightly pricing in geopolitical risks.
Merck & Co. shifts its cancer drug development playbook, opting for targeted collaborations with Guardant Health and Eikon Therapeutics after walking away from a major acquisition. Analysts debate whether the stock's current price fully reflects its long-term pipeline potential.
Tetra Tech's stock has surged following strong Q1 results, raised guidance, and enhanced capital returns. While analysts see further upside, questions linger over contract risks and a premium valuation.
Viasat shares have rocketed 31% in a month, reigniting investor debate over whether the satellite communications firm is a hidden gem or a momentum-driven play facing stiff competition from SpaceX's Starlink and Amazon's Project Kuiper.
Marketing technology firm Zeta Global announces a strategic collaboration with OpenAI, aiming to deeply integrate advanced AI into its platform. The move, coupled with positive buzz from CES 2026, sharpens its competitive edge in a sector dominated by giants like Salesforce and Adobe.
